Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Market Insights | Europe | 2019

A highly cost-conscious health care landscape in Europe has placed substantial downward pressure on the large yet contracting European IC device market. However, an expanding CAD patient pool, continued innovation, and increasing adoption of premium-priced devices—such as next-generation DESBVSDCBs, and intravascular imaging catheters and pressure guidewires—will mitigate overall revenue declines and fuel expansion in certain segments, including those for BVS and intravascular imaging catheters and pressure guidewires. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period because of rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and increased…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…